Aurora, Colorado Clinical Trials
A listing of Aurora, Colorado clinical trials actively recruiting patient volunteers.
Found 753 clinical trials
Caregiver-Provided Life Review for Persons with Dementia in Care Facilities
This study, Caregiver-Provided Life Review (C-PLR) is created based on Life Review therapy. It is for persons living with early-stage dementia along with mild depressive symptoms who are 65 years or older, community-dwellers or the residents of senior housing, independent or assisted living facilities conducted by their family members (18 …
- 485 views
- 30 Jun, 2022
- 1 location
- Online study
Repetitive Behavior in Early Childhood
The University of Minnesota is seeking family caregivers of children between the ages of 2 and 6 with and without developmental delays to respond to a survey. The purpose of this survey is to learn more about the development of repetitive behavior in early childhood. The survey is fully virtual …
- 19 views
- 30 Jun, 2022
- 1 location
- Online study
Evaluating the Psychometric Properties of Three Clinical Trial Outcome Measures for Rett Syndrome
Evaluating the Psychometric Properties of Three Clinical Trial Outcome Measures for Rett Syndrome: The purpose of this research study is to document the psychometric properties of three non-invasive, clinic-friendly, and quantifiable outcome measures reflecting pathologically- and clinically-relevant symptoms of Rett Syndrome (RTT). Despite several ongoing or pending clinical trials for …
- 11 views
- 30 Jun, 2022
- 1 location
- Online study
Retrospective study examining the differences in vocalizations of babies and toddlers with Rett compared to same age peers
Retrospective study examining the differences in vocalizations of babies and toddlers with Rett compared to same age peers: We are looking to recruit children and their parent(s) to participate in a study examining the early speech development of infants and toddlers later diagnosed with Rett syndrome, compared to girls their …
- 20 views
- 30 Jun, 2022
- 1 location
- Online study
Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).
This study is a Phase 3 global, multicenter, placebo-controlled double-blind randomized study that will enroll participants with inoperable locally recurrent or metastatic SCAC not previously treated with systemic chemotherapy.
- 1245 views
- 30 Jun, 2022
- +83 other locations
Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).
This study is a Phase 3 global, multicenter, placebo-controlled double-blind randomized study that will enroll participants with inoperable locally recurrent or metastatic SCAC not previously treated with systemic chemotherapy.
- 10 views
- 30 Jun, 2022
- +80 other locations
A Trial Evaluating Different Dosing Durations of TEPEZZA® Treatment in Patients with Thyroid Eye Disease (TED)
The overall objective is to investigate the safety, tolerability and need for re-treatment of 3 different TEPEZZA® treatment durations (4, 8, or 16 infusions) in patients with TED.
- 8 views
- 29 Jun, 2022
- +7 other locations
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects
Our team of medical professionals is evaluating an investigational drug that is designed to slow the progression of Alzheimer’s disease. The study drug, ALZ-801, is a tablet that is taken twice daily. It has been well tolerated in earlier studies and may be a convenient option for Alzheimer’s patients and …
- 62 views
- 29 Jun, 2022
- +78 other locations
A Study to Assess the Safety of BIIB122 Tablets and if it Can Slow the Worsening of Early-Stage Parkinson's Disease in Participants Between the Ages of 30 and 80
In this study, researchers will learn more about a study drug called BIIB122 in participants with early-stage Parkinson's disease (PD). In this study: Participants will take 225 milligrams (mg) of BIIB122 or a placebo as tablets by mouth. A placebo looks like the study drug but has no real medicine …
- 3 views
- 03 Jul, 2022
- +3 other locations
INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma
The purpose of this study is to evaluate the safety and antitumor activity of INCB001158 in combination with daratumumab SC, compared with daratumumab SC alone, in participants with relapsed or refractory multiple myeloma who have received at least 3 but not more than 5 prior lines of multiple myeloma therapy. …
- 186 views
- 10 May, 2022
- +27 other locations